L90.1
Anetoderma of Schweninger-Buzzi
Clinical Classification Guidelines
Medical Intelligence & Overview
Anetoderma of Schweninger-Buzzi is a rare skin condition characterized by the loss of elastic tissue within the skin, leading to localized areas of slackness or pouching. This condition results in soft, baggy patches on the skin that often have a slightly depressed appearance. Although it mainly affects the skin's elastic fibers, the disease does not usually involve other tissues and is considered a benign skin disorder. It primarily impacts young adults and middle-aged individuals, with no significant preference for a specific gender. Understanding this condition can help patients recognize its features and seek appropriate medical evaluation and management.
Causes & Symptoms
Clinical Causes: Underlying skin inflammation or infection Autoimmune responses causing damage to elastic tissue Previous skin injuries or trauma Certain connective tissue diseases or systemic illnesses Idiopathic origins (unknown cause) Associations with conditions such as tuberculosis or leprosy (though rare)
Key Symptoms: Localized, soft, pouch-like or wrinkled skin patches Areas often appear slightly depressed compared to surrounding skin Size varies, ranging from small spots to larger patches Skin may be asymptomatic, with no pain or itching Affected areas are usually stable over time but can enlarge or multiply Common sites include the trunk, arms, and legs
Diagnostic & Treatment
Diagnosis Path: Diagnosis of anetoderma of Schweninger-Buzzi involves physical examination of skin lesions, noting their characteristic features such as pouching and softness. A skin biopsy is often performed to confirm the diagnosis, revealing focal loss of elastic fibers in the dermis under microscopic examination. Additional tests may include histopathology with special stains for elastic tissue. Medical history and clinical presentation help differentiate it from other skin conditions with similar features, such as eczema or atrophic scars.
Treatment Protocols: There is no universally effective treatment for anetoderma of Schweninger-Buzzi, and management primarily focuses on monitoring and cosmetic considerations. In some cases, therapies intended to stimulate elastic tissue regeneration or improve skin firmness have been attempted, though with limited success. Laser therapy or surgical procedures might be considered for cosmetic improvement but are not definitive. Patients are advised to protect affected skin from trauma and sun exposure and to consult dermatologists for individualized management plans.
Clinical Advice & FAQs
Billing Guidance
Is L90.1 a billable ICD-10 code?
Yes, L90.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L90.1?
Clinical documentation must specify the nature of Anetoderma of Schweninger-Buzzi and any associated comorbidities for accurate reporting.
Cite this Clinical Reference